MiNK Therapeutics | 10-K: Annual report
Mar 21 16:07 ET
MiNK Therapeutics | 8-K: MiNK Reports Fourth Quarter and Year-End 2023 Results
Mar 21 07:05 ET
MiNK Therapeutics | 4: Statement of changes in beneficial ownership of securities-Director Corvese Brian
Mar 5 18:06 ET
MiNK Therapeutics | 4: Statement of changes in beneficial ownership of securities-Director Behner Peter
Mar 5 18:04 ET
MiNK Therapeutics | 4: Statement of changes in beneficial ownership of securities-Director Ryan Barbara
Mar 5 18:04 ET
MiNK Therapeutics | 4: Statement of changes in beneficial ownership of securities-Director WIINBERG ULF
Mar 5 18:04 ET
MiNK Therapeutics | 8-K: Current report
Feb 29 16:18 ET
MiNK Therapeutics | SC 13D: Statement of acquisition of beneficial ownership by individuals-Garo H. Armen(9.68%),The Garo H. Armen Grantor Retained Annuity Trust Agreement 2023 #1(1.90%), etc.
Feb 14 18:09 ET
MiNK Therapeutics | 8-K: Current report
Feb 14 08:04 ET
MiNK Therapeutics | 4: Statement of changes in beneficial ownership of securities-Officer van Dijk Marcus Antonius
Jan 18 00:00 ET
MiNK Therapeutics | 4: Statement of changes in beneficial ownership of securities-Officer Buell Jennifer
Jan 18 00:00 ET
MiNK Therapeutics | 4: Statement of changes in beneficial ownership of securities-Director Ryan Barbara
Dec 5, 2023 18:11 ET
MiNK Therapeutics | 4: Statement of changes in beneficial ownership of securities-Director Corvese Brian
Dec 5, 2023 18:05 ET
MiNK Therapeutics | 4: Statement of changes in beneficial ownership of securities-Director WIINBERG ULF
Dec 5, 2023 18:05 ET
MiNK Therapeutics | 4: Statement of changes in beneficial ownership of securities-Director Behner Peter
Dec 5, 2023 18:05 ET
MiNK Therapeutics: Q3 2023 Earnings Report
Nov 14, 2023 17:17 ET
MiNK Therapeutics | 8-K: Current report
Nov 9, 2023 07:00 ET
MiNK Therapeutics | 8-K: Current report
Oct 17, 2023 16:15 ET
MiNK Therapeutics | 4: Statement of changes in beneficial ownership of securities-10% Owner AGENUS INC
Oct 16, 2023 17:49 ET
MiNK Therapeutics | 4: Statement of changes in beneficial ownership of securities-Chief Executive Officer Buell Jennifer
Oct 13, 2023 20:18 ET
No Data
No Data